3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Leukemia, Myeloid, Acute
16
Myelodysplastic Syndromes
9
Lung Neoplasms
5
Myeloproliferative Disorders
4
Leukemia, Myelomonocytic, Chronic
4
Sarcoma
3
Prostatic Neoplasms
3
Ovarian Neoplasms
3
Head and Neck Neoplasms
3
Breast Neoplasms
3
Stomatitis
2
Primary Myelofibrosis
2
Neoplasm Metastasis
2
Multiple Myeloma
2
Mucositis
2
Melanoma
2
Lymphoma, Non-Hodgkin
2
Leukemia, Monocytic, Acute
2
Leukemia, Lymphocytic, Chronic, B-Cell
2
Leukemia, Biphenotypic, Acute
2
Disease
2
Carcinoma, Non-Small-Cell Lung
2
Uveal Melanoma
1
Uterine Cervical Neoplasms
1
Triple Negative Breast Neoplasms
1
Thrombocythemia, Essential
1
Squamous Cell Carcinoma of Head and Neck
1
Sarcoma, Synovial
1
Prostate Cancer Metastatic
1
Polycythemia Vera
1
Interventions
Gemcitabine
31
Cisplatin
21
pembrolizumab
8
Fluorouracil
6
Oxaliplatin
5
Capecitabine
5
130-nm albumin-bound paclitaxel
5
durvalumab
4
Taxes
4
Albumin-Bound Paclitaxel
4
pemigatinib
3
infigratinib
3
atezolizumab
3
Specimen Handling
3
Radiosurgery
3
Platinum
3
Magnetic Resonance Spectroscopy
3
Leucovorin
3
Carboplatin
3
Biopsy
3
1,2-diaminocyclohexaneplatinum II citrate
3
tremelimumab
2
trametinib
2
olaparib
2
ivosidenib
2
derazantinib
2
cobimetinib
2
Trastuzumab
2
Radiotherapy
2
Panitumumab
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Cholangiocarcinoma
×
Injections
×
Clear all
No trials found.